The object of this paper is to report our experience, discuss briefly the indications for respirator therapy and the management, and consider the effect of this on the long-term prognosis.
Material
During the period 1960-68 some 15 patients were admitted to the Respiratory Unit at Manchester Royal Infirmary: 10 were unresponsive to drug therapy; 2 were admitted following thymectomy and were able to return to the ward within a few days. Two others, not in respiratory difficulty, were admitted as a precaution during a course of intensive therapy with adrenocorticotrophic hormone and these were also discharged after a few days. The remaining patient with myasthenia gravis was in acute respiratory and circulatory failure and died within a few hours; at autopsy she was found to have massive pulmonary embolism.
The clinical features in the 10 patients who were unresponsive to drug therapy are summarized in Table 1 . There were 8 women and 2 men; the mean age at onset of the disease was 38-3 years. This is a significantly later onset than the series of 320 patients reviewed by Simpson (1958) with mean age of onset 27-6 years. The group of 10 patients accounted for 22 admissions to the Respiratory Unit for periods from a few days to six months. Respiratory failure was never the first symptom of the disease though it was sometimes the reason for referral. The interval of time from the first symptom to the onset of respiratory failure was from six months to eight years with a mean of 2j years.
Assessment
The need for respirator treatment was assessed clinically, although all facilities for laboratory and respiratory assessment were available and used in controlling the treatment. The onset was often sudden but usually preceded by several days of respiratory difficulty and not infrequently associated with an attack of the common cold. Sputum retention was often a contributory factor. Bulbar paralysis greatly complicated the respiratory difficulties of these patients by added respiratory obstruction due to inability to swallow pharyngeal secretions.
Edrophonium chloride (Tensilon) was used to assess drug-responsiveness. In some of the earlier cases the full dose of 10 mg was given intravenously and on three occasions this was followed by a marked deterioration. We now use a dose of 2 mg in patients already treated with cholinergic drugs as recommended by Osserman & Genkins (1966) . Management The management was conventional. An endotracheal tube was inserted initially. After three days, or sometimes sooner, this was replaced by a tracheostomy and a cuffed rubber tube. Drug therapy was stopped. When intermittent positive pressure respiration had been established it was found more satisfactory to maintain it for at least three days. Several attempts were made to allow the patient to breathe spontaneously after a few hours but this always failed and caused considerable distress. When the need for respirator therapy had passed the rubber cuffed tube was replaced by a metal tube of the Negus type and this was left in position. It was noted that these patients with myasthenia were often depressed. In this respect they contrasted sharply with other patients receiving respirator treatment who are usually cheerful, especially when they are obviously making progress towards recovery.
Results
The long-term results were disappointing. One patient died after a year and was found at autopsy to have a malignant thymoma. This was not revealed in chest radiographs and illustrates the difficulty of diagnosing these tumours. Although her symptoms began at 61 years it is well known that myastatia gravis may present in old age. Six other patients died during the follow up; some of thme had r rt respiratory failure. The period Of survival after the respiratory failure was 1 to 7 years witha n of 3 3years.
There were 3 survivors. One patient was admittod i failuire at the 24th week of Er~p~*ncy. The chid was severely yasthenic at birth and died after 18 hours of artificial ventilation of its lungs. During the puerperium there was a striking remission of the myasthenia and she, is now controlled with neostigmine but has not had any further respiratory distress. Another patient developed respiratory failure folHowing thymetomy but improved in a few days; six minths later she had a further brief episode but control was salfactory during the subsequent eight years. The third survivor had a single short episode of respiratory failure which Was attributed to overdosaw of drus and itre was no recurrence durWinthe next seven years.
None of the pa died during arti&ial respiration. It is wll known that sudden death occurs in patients with myasthenia gravis. Te deaths in this senes were sudden and not preceded by respiratory distress. It seems possi-ble that circutory factors were significnt. Two patients died following abdominal operaton and the effect oeostgmie is ofpossible imprtance in these. It has been shown that the use of neostigmine as a single-dose antidote to curare-type drugs in anesthesia for nonmyasthenic patients is associated with a higher incidefice of leakae from intefstnal anastomosis (Bell & Lewis 1968).
Myasthenic patipnts receive large doses ofneostigmine and often develop colic and other-intestinal symptoms which can be controlled with drugs of the atropine group. It is not unreasonable to ex-pect such bowel activity to have an advrs effect on a recent intestinal anastomosis.
After thymectomy the neostigmine requirement may change and it is important to avoid excessive dosage in the immediate post-operative phase. The success of public health environmental control has led to the virtual elimination f lethal inftiou disease in Wester Europe and to a greatl increased impotance of cngeital malformations and dIg_enerive diseatis which are partly geetic. Although some diseases appear to be 'purey' environ ntal in origin and some 'purely' genetic, conmon disease is usually nmltifatorial. Autosomal recessive traits are, however, in th e a p also responsible for much diease and prM*bay fotal loss: all of us are probably heterozygotes for 3-5 lethal autosomal recessive traits.
Conclusion

